BACKGROUND: Current guidelines concerning the treatment of patients with chronic congestive heart failure (CHF) include ergospirometry-directed dynamic exercises on a daily basis. Several prospective, randomized trials have confirmed its positive influence on clinical symptoms and prognosis of the disease. Patients with stable coronary artery disease (CAD) can benefit from a 27% reduction of mortality, as shown in meta-analyses of several studies. By contrast, patients with CHF have traditionally been discouraged from physical activities, which may have had detrimental consequences. They became even less able to participate in daily activities that in turn hastened the disease-driven atrophies of skeletal muscles. On the other hand, well-adjusted endurance training at 50-70% of maximum oxygen uptake was shown to improve overall fitness. In a recent metaanalysis, the mortality of patients with CHF was reduced by 35% by sports, and the rate of hospitalizations dropped by 28%. It is a well-perceived clinical problem that successful treatment is not possible without intensive guidance and a close therapeutic relationship. Being left in their routine situation and circumstances, the majority of patients cannot cope with the day-to-day challenge of an independent, active lifestyle. Among the primary reasons not to sustain physical activity are mental, psychological or social barriers. PATIENTS AND METHODS: The authors have begun, in a cohort of patients with CHF, a prospective pilot study to investigate the impact of, and attitude to, electromyostimulation (EMS). Unique features of this treatment include its passive nature that remains independent of mental attitude. RESULTS: An up to 96% increase of peak oxygen uptake at the anaerobic threshold could be shown (pre- vs. posttraining phase, VO(2at) 19.39 [+/- 5.3] ml/kg vs. 24.25 [+/- 6.34] ml/kg). The diastolic blood pressure decreased significantly. A 14% gain in muscle volume was observed, while overall body weight remained unchanged. All patients kept up the training until the conclusion of the study and found their overall fitness to be considerably improved. CONCLUSION: The results may indicate the enormous potential of EMS for the treatment of patients within the cardiologic arena, especially those with CHF.
BACKGROUND: Current guidelines concerning the treatment of patients with chronic congestive heart failure (CHF) include ergospirometry-directed dynamic exercises on a daily basis. Several prospective, randomized trials have confirmed its positive influence on clinical symptoms and prognosis of the disease. Patients with stable coronary artery disease (CAD) can benefit from a 27% reduction of mortality, as shown in meta-analyses of several studies. By contrast, patients with CHF have traditionally been discouraged from physical activities, which may have had detrimental consequences. They became even less able to participate in daily activities that in turn hastened the disease-driven atrophies of skeletal muscles. On the other hand, well-adjusted endurance training at 50-70% of maximum oxygen uptake was shown to improve overall fitness. In a recent metaanalysis, the mortality of patients with CHF was reduced by 35% by sports, and the rate of hospitalizations dropped by 28%. It is a well-perceived clinical problem that successful treatment is not possible without intensive guidance and a close therapeutic relationship. Being left in their routine situation and circumstances, the majority of patients cannot cope with the day-to-day challenge of an independent, active lifestyle. Among the primary reasons not to sustain physical activity are mental, psychological or social barriers. PATIENTS AND METHODS: The authors have begun, in a cohort of patients with CHF, a prospective pilot study to investigate the impact of, and attitude to, electromyostimulation (EMS). Unique features of this treatment include its passive nature that remains independent of mental attitude. RESULTS: An up to 96% increase of peak oxygen uptake at the anaerobic threshold could be shown (pre- vs. posttraining phase, VO(2at) 19.39 [+/- 5.3] ml/kg vs. 24.25 [+/- 6.34] ml/kg). The diastolic blood pressure decreased significantly. A 14% gain in muscle volume was observed, while overall body weight remained unchanged. All patients kept up the training until the conclusion of the study and found their overall fitness to be considerably improved. CONCLUSION: The results may indicate the enormous potential of EMS for the treatment of patients within the cardiologic arena, especially those with CHF.
Authors: S Adamopoulos; J Parissis; C Kroupis; M Georgiadis; D Karatzas; G Karavolias; K Koniavitou; A J Coats; D T Kremastinos Journal: Eur Heart J Date: 2001-05 Impact factor: 29.983
Authors: Luiz Rodrigues-Santana; Hugo Louro; Ángel Denche-Zamorano; Alejandro Vega-Muñoz; Nicolás Contreras-Barraza; Jose Carmelo Adsuar Journal: Int J Environ Res Public Health Date: 2022-04-13 Impact factor: 4.614
Authors: Larissa Delgado André; Renata Pedrolongo Basso-Vanelli; Paula Angélica Ricci; Luciana Di Thommazo-Luporini; Claudio Ricardo de Oliveira; Guilherme Focchi Haddad; José Michel Haddad; Nivaldo Antonio Parizotto; Rodolfo de Vieira; Ross Arena; Audrey Borghi-Silva Journal: Int J Obes (Lond) Date: 2021-04-29 Impact factor: 5.095
Authors: Wolfgang Kemmler; Matthias Kohl; Ellen Freiberger; Cornel Sieber; Simon von Stengel Journal: BMC Geriatr Date: 2018-03-09 Impact factor: 3.921
Authors: Wolfgang Kemmler; Anja Weissenfels; Sebastian Willert; Mahdieh Shojaa; Simon von Stengel; Andre Filipovic; Heinz Kleinöder; Joshua Berger; Michael Fröhlich Journal: Front Physiol Date: 2018-05-23 Impact factor: 4.566
Authors: Wolfgang Kemmler; Simon von Stengel; Matthias Kohl; Nicolas Rohleder; Thomas Bertsch; Cornel C Sieber; Ellen Freiberger; Robert Kob Journal: Clin Interv Aging Date: 2020-06-24 Impact factor: 4.458
Authors: Kristin Schink; Hans J Herrmann; Raphaela Schwappacher; Julia Meyer; Till Orlemann; Elisabeth Waldmann; Bernd Wullich; Andreas Kahlmeyer; Rainer Fietkau; Dorota Lubgan; Matthias W Beckmann; Carolin Hack; Wolfgang Kemmler; Jürgen Siebler; Markus F Neurath; Yurdagül Zopf Journal: BMC Cancer Date: 2018-09-12 Impact factor: 4.430